Citation: C. Barbui et S. Garattini, STUDI CLINICI CONTROLLATI E NUOVI PSICOFARMACI: ALCUNE CONSIDERAZIONI DI METODO, Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali Archivio italiano per le malattie nervose e mentali. Rivista sperimentale di freniatria e medicina legale delle alienazioni mentali , CXXIII(1), 1999, pp. 1-9
Citation: S. Garattini et L. Garattini, DISCREPANCY REMAINS IN PHARMACEUTICAL PRESCRIPTIONS IN 4 EUROPEAN COUNTRIES, BMJ. British medical journal, 317(7163), 1998, pp. 947-947
Citation: S. Garattini et al., ANTIDEPRESSANT AGENTS - FROM TRICYCLICS TO SEROTONIN UPTAKE INHIBITORS, Psychological medicine, 28(5), 1998, pp. 1169-1178
Citation: S. Garattini, PHARMACOLOGY OF AMINEPTINE, AN ANTIDEPRESSANT AGENT ACTING ON THE DOPAMINERGIC SYSTEM - A REVIEW, International clinical psychopharmacology, 12, 1997, pp. 15-19
Authors:
CACCIA S
CONFALONIERI S
BERGAMI A
FRACASSO C
ANELLI M
GARATTINI S
Citation: S. Caccia et al., NEUROPHARMACOLOGICAL EFFECTS OF LOW AND HIGH-DOSES OF REPEATED ORAL DEXFENFLURAMINE IN RATS - A COMPARISON WITH FLUOXETINE, Pharmacology, biochemistry and behavior, 57(4), 1997, pp. 851-856
Authors:
BELGRANO EA
NARDELLA L
PONZIO F
NESSI F
GUALA A
MAZZUCCHETTI S
GRAZIANO L
URBAN I
PALOMBO D
BRUSTIA P
CALZONI D
BELLONE M
ALTIERI M
AGUS GB
DEANGELIS R
MARROCU R
GROSSI A
FRIGERIO D
BIASI GM
PIGLIONICA MR
AGRIFOGLIO G
COSTANTINI A
DELLAVEDOVA MR
MIGLIERINA L
LAVORATO F
EMANUELLI G
ROSSI R
FLANDOLI C
PONTI GB
BERRA S
LOSAPIO GM
INZOLI MR
LOMBARDI G
TARANTOLA P
ZOCCA N
SFORZA M
RUSSO R
TENCHINI P
BRUNI T
FONTANILI M
GUIDETTI D
ODERO A
SALVINI M
PEDEFERRI G
BORDONI MC
VEDOVATO F
BITTOLO BG
MAFFEI L
MARCON G
DELLOLIVO I
GRACCO L
PETRALIA G
CORDIANO C
DORUCCI V
PAGNAN A
VISONA A
TONIETTO G
AGRESTA F
FAVRETTI F
BURIGO E
GIANSANTE C
FIOTTI N
PAMICH G
SANTIROCCO C
MOZZON L
GONANO N
PETRILLI GL
PUZZO A
BALDINOG G
PODESTA A
GUASTINI A
TRAVERSARO A
ZINICOLA N
BAGLIETTO F
BORGATTI E
FILIPPINI M
FERRARI F
COPPI G
CAMPARINI S
TUSCANO G
LONARDI R
BOTTA GC
BANCHINI E
PAVARINI E
DELMONTE E
BUCHERINI E
MORATTI A
IERAN M
BERTINI D
PRATESI C
CORSI C
POLLASTRI M
MARRAPODI E
VANNI D
RALLI L
CECCHI M
BIGALLI A
DELCARRATORE G
MOSCA F
VATTERONI F
SETACCI C
CAO P
VERZINI F
MANNARINO E
PASQUALINI L
FEDELI F
ALO F
IOANNIDIS G
SPARTERA C
MARINO G
MEDORI M
POLA P
DALLAGO AA
DIGIOVANANI V
COLLI R
MANISCALCO G
BARTOLO M
TODINI AR
BENEDETTIVALENTINI F
IRACE L
FIORANI P
TAURINO M
MARCIALIS A
VALITUTTI P
VIGLIOTTI G
REGINA G
FULLONE M
RIZZO S
ROLLI F
PASCALI M
LUCENTINI L
GRILLI M
CORRERA H
FLORENA M
CASSINA I
NOTARBARTOLO A
BELVEDERE M
ANDREOZZI GM
DIPINO L
MARTINI R
SIGNORELLI S
CAVALLARO S
PULEO R
ROMEO S
CORMACI OF
COSTANZO C
GRASSO A
AVANZINI F
BEDONI P
BERTELE V
COLOMBO F
FELLIN G
PANGRAZZI J
RONCAGLIONI MC
SAMORI G
TOGNONI G
DEGAETANO G
GARATTINI S
Citation: Ea. Belgrano et al., A PROSPECTIVE EPIDEMIOLOGIC SURVEY OF THE NATURAL-HISTORY OF CHRONIC CRITICAL LEG ISCHEMIA, European journal of vascular and endovascular surgery, 11(1), 1996, pp. 112-120
Authors:
BARBUI C
SARACENO B
LIBERATI A
GARATTINI S
Citation: C. Barbui et al., LOW-DOSE NEUROLEPTIC THERAPY AND RELAPSE IN SCHIZOPHRENIA - METAANALYSIS OF RANDOMIZED CONTROLLED TRIALS, European psychiatry, 11(6), 1996, pp. 306-313
Authors:
DEVITA C
FAZZINI PF
GERACI E
TAVAZZI L
TOGNONI G
VECCHIO C
BOERI R
DAMICO G
LOI U
MARUBINI E
PAGLIARO L
ROVELLI F
FRANZOSI MG
LATINI R
MAGGIONI AP
MAURI F
VOLPI A
BARLERA S
NEGRI E
NICOLIS E
SANTORO E
SANTORO L
ASCIONE A
BONFANTI E
CAPELLO T
CASATI A
CORATO A
GARDINALE E
NEGRINI M
NOBILI A
STASZEWSKY L
TAVANELLI M
TORTA D
ZUANETTI G
GAMBELLI G
MORONI L
PELLANDA JJ
PIETROPAOLO F
BALLI E
BARBIERI A
BECHI S
CARRONE M
CATANZARO M
FASCIOLO L
FRESCO C
GHIANI A
IACUITTI G
LEDDA A
LEVANTESI G
MORONI L
PASINI P
PECI P
PIZZETTI F
SAGONE A
TURAZZA F
VILLELLA A
VILLELLA M
BRAGGIO N
DISERTORI M
FREZZATI S
GARATTINI S
MARINO P
MASERI A
MAZZOTTA G
NICOLOSI G
PIRELLI S
SANNA GP
VALAGUSSA F
DARGIE HJ
PETO R
POCOCK S
SLEIGHT P
YUSUF S
Citation: C. Devita et al., 6-MONTH EFFECTS OF EARLY TREATMENT WITH LISINOPRIL AND TRANSDERMAL GLYCERYL TRINITRATE SINGLY AND TOGETHER WITHDRAWN 6 WEEKS AFTER ACUTE MYOCARDIAL-INFARCTION - THE GISSI-3 TRIAL, Journal of the American College of Cardiology, 27(2), 1996, pp. 337-344
Authors:
MENNINI T
FRACASSO C
CAGNOTTO A
BERGAMI A
FRITTOLI E
GOBBI M
CACCIA S
GARATTINI S
Citation: T. Mennini et al., IN-VITRO AND IN-VIVO EFFECTS OF THE ANORECTIC AGENT DEXFENFLURAMINE ON THE CENTRAL SEROTONINERGIC NEURONAL SYSTEMS OF NONHUMAN-PRIMATES - ACOMPARISON WITH THE RAT, Naunyn-Schmiedeberg's archives of pharmacology, 353(6), 1996, pp. 641-647
Authors:
GHEZZI P
GARATTINI S
MENNINI T
BERTINI R
HERNANDEZ RD
BENIGNI F
SACCO S
SKORUPSKA M
MENGOZZI M
LATINI R
KUROSAKI M
LOMBET A
FRADIN A
BONNET J
ROLLAND Y
BRION JD
Citation: P. Ghezzi et al., MECHANISM OF INHIBITION OF TUMOR-NECROSIS-FACTOR PRODUCTION BY CHLORPROMAZINE AND ITS DERIVATIVES IN MICE, European journal of pharmacology, 317(2-3), 1996, pp. 369-376
Authors:
DOUGADOS M
DEVOGELAER JP
ANNEFELDT M
AVOUAC B
BOUVENOT G
COOPER C
DIEPPE P
ETHGEN D
GARATTINI S
JONES EA
KAUFMAN JM
LEEMING M
LEMMEL EM
LOHMANDER S
MENKES CJ
NUKI G
PAOLOZZI L
PUJOL JP
ROVATI L
SERNI U
SPECTOR T
TSOUDEROS Y
VEYS EM
WESELOH G
REGINSTER JY
Citation: M. Dougados et al., RECOMMENDATIONS FOR THE REGISTRATION OF DRUGS USED IN THE TREATMENT OF OSTEOARTHRITIS, Annals of the Rheumatic Diseases, 55(8), 1996, pp. 552-557
Authors:
ANELLI M
FRACASSO C
BERGAMI A
FERRARESE A
GARATTINI S
CACCIA S
Citation: M. Anelli et al., EFFECT OF D-FENFLURAMINE ON THE INDOLE CONTENTS OF THE RAT-BRAIN AFTER TREATMENT WITH DIFFERENT INDUCERS OF CYTOCHROME-P450 ISOENZYMES, Psychopharmacology, 118(2), 1995, pp. 188-194